Business / Finance

RSS

ChromaDex reports 31% revenue growth in first quarter 2013

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the first quarter ended March 30, 2013.

10 May 2013

Echo Therapeutics reports net loss of $7.0 million for first quarter 2013

Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.

10 May 2013

Yongye International revenue decreases 29.7% to $45.3M in first quarter 2013

Yongye International, Inc., a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China, today announced its financial results for the quarter ended March 31, 2013.

10 May 2013

Small diameter dual-thread suture anchor and new PTRC repair system launched by Mitek Sports Medicine

Mitek Sports Medicine, a leading orthopaedics sports medicine company, announced the launch of the HEALIX™ 3.4mm Suture Anchor, the company's smallest dual-thread suture anchor for rotator cuff repair, and the launch of a new double-loaded minimally invasive partial thickness rotator cuff (PTRC) repair system, as part of its HEALIX TRANSTENDTM Implant System.

9 May 2013

Gentiva Health Services net revenues decrease 5% to $415.6M in first quarter 2013

Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, today reported first quarter 2013 results.

9 May 2013

Columbia Laboratories net revenues increase 65% to $6.3 million in first quarter 2013

Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2013.

9 May 2013

CCIM institute accepts UT Dallas as university partner

The CCIM Institute has accepted UT Dallas as a university partner, putting graduate students in real estate on the fast track to earning its prestigious expert designation.

8 May 2013

POZEN announces revenue of $1.4 million for first quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2013.

8 May 2013

Good Start Genetics gets $28M loan from Capital Royalty

Good Start Genetics, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty L.P.

8 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

Handheld ultrasound device from Signostics receives 510K clearance from the FDA

Handheld ultrasound device manufacturer Signostics has received a major boost with 510(k) clearance from the US Food and Drug Administration (FDA) to market its new Signos RT to the lucrative American market.

7 May 2013

Cost-effective endoscopic system for urological procedures launched by Cook Medical

A new, cost-effective endoscopic option is now available to urologists. Physicians can use the Flexor® Vue™ Deflecting Endoscopic System during urological procedures to access and visualize body cavities or organs.

7 May 2013

Targacept reports net loss of $8.1 million in first quarter 2013

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2013.

7 May 2013

Rigel reports net loss of $25.6 million in first quarter 2013

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.

7 May 2013

Perrigo net sales increase 18% to $920M in third quarter 2013

Perrigo Company today announced results for its third quarter ended March 30, 2013.Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered all-time record quarterly revenue and adjusted diluted earnings per share.

7 May 2013

Nuvo Research intends to proceed with its proposed share consolidation

Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.

7 May 2013

Biocryst reports financial results for first quarter 2013

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2013.

7 May 2013

Akorn reports record consolidated revenue of $73.9 million in first quarter 2013

Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013.

7 May 2013

Hospital for Special Surgery signs agreement with Brazilian healthcare organization

Clinical pathways and quality initiatives leading to world class outcomes are the foundation of a far-reaching agreement between New York-based Hospital for Special Surgery, the recognized leader in orthopedics, rheumatology and related specialties, and Amil Par, the largest managed healthcare organization in Brazil, on behalf of Hospitalys Ortopedia, its newly opened orthopedic center in Rio de Janeiro.

7 May 2013

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round.

6 May 2013

Business / Finance

ChromaDex reports 31% revenue growth in first quarter 2013

Echo Therapeutics reports net loss of $7.0 million for first quarter 2013

Yongye International revenue decreases 29.7% to $45.3M in first quarter 2013

Small diameter dual-thread suture anchor and new PTRC repair system launched by Mitek Sports Medicine

Gentiva Health Services net revenues decrease 5% to $415.6M in first quarter 2013

Columbia Laboratories net revenues increase 65% to $6.3 million in first quarter 2013

CCIM institute accepts UT Dallas as university partner

POZEN announces revenue of $1.4 million for first quarter 2013

Good Start Genetics gets $28M loan from Capital Royalty

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Handheld ultrasound device from Signostics receives 510K clearance from the FDA

Cost-effective endoscopic system for urological procedures launched by Cook Medical

Targacept reports net loss of $8.1 million in first quarter 2013

Rigel reports net loss of $25.6 million in first quarter 2013

Perrigo net sales increase 18% to $920M in third quarter 2013

Nuvo Research intends to proceed with its proposed share consolidation

Biocryst reports financial results for first quarter 2013

Akorn reports record consolidated revenue of $73.9 million in first quarter 2013

Hospital for Special Surgery signs agreement with Brazilian healthcare organization

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News